Testimony of Ethan Nadelmann in Support of a Heroin-assisted Treatment Pilot Program in Nevada

On April 7, 2015, Ethan Nadelmann, Executive Director of the Drug Policy Alliance, presented oral testimony in support of sections 11-20 of SB275 at a hearing of the Nevada State Senate Revenue and Economic Development Committee. Nadelmann also submitted complementary written testimony. SB275 would create a four-year heroin-assisted treatment pilot program—the first in the United States. Heroin-assisted treatment is a feasible, effective, and cost-saving strategy for reducing drug use and drug-related harm among long-term heroin users for whom other treatment programs have failed. Nadelmann’s testimony highlights the development and history of heroin-assisted treatment in other countries, reviews the compelling evidence base that has been amassed from the international experience, and contextualizes the importance of SB275 within our own country and Nevada.

Office of Legal Affairs
Drug Replacement and Maintenance Therapy
Drug Treatment
Harm Reduction
Heroin-Assisted Treatment
Statement of Support